Responding to an independent review of NASA's ambitious Mars Sample Return mission, agency officials said Monday they will seek fresh ideas from agency engineers, researchers and the private sector to ...

During his final months as the chief of NASA’s science programs last year, there was one mission Thomas Zurbuchen fretted about more than any other—the agency’s ambitious plan to return rocks from ...

Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its revenue, a top ...